Jpmorgan Chase & CO Mirum Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 287,936 shares of MIRM stock, worth $12.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

287,936

Previous 385,142 25.24%

Holding current value

$12.8 Million

Previous $15.9 Million 18.55%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$41.32 - $53.16 $4.02 Million - $5.17 Million	-97,206 Reduced 25.24%	287,936 $13 Million
Q4 2024 Feb 12, 2025	BUY	$37.85 - $46.65 $13.5 Million - $16.7 Million	357,381 Added 1287.35%	385,142 $15.9 Million
Q3 2024 Dec 26, 2024	BUY	$33.68 - $44.74 $132,328 - $175,783	3,929 Added 16.49%	27,761 $1.08 Million
Q3 2024 Nov 08, 2024	BUY	$33.68 - $44.74 $132,328 - $175,783	3,929 Added 16.49%	27,761 $1.08 Million
Q2 2024 Dec 26, 2024	SELL	$23.57 - $34.85 $92,606 - $136,925	-3,929 Reduced 14.15%	23,832 $814,000
Q2 2024 Aug 12, 2024	SELL	$23.57 - $34.85 $2.87 Million - $4.24 Million	-121,728 Reduced 83.63%	23,832 $814,000
Q1 2024 Dec 26, 2024	BUY	$24.92 - $30.02 $2.94 Million - $3.54 Million	117,799 Added 424.33%	145,560 $3.66 Million
Q1 2024 May 10, 2024	SELL	$24.92 - $30.02 $1.02 Million - $1.23 Million	-41,023 Reduced 21.99%	145,560 $3.66 Million
Q4 2023 Dec 26, 2024	BUY	$27.14 - $34.93 $4.31 Million - $5.55 Million	158,822 Added 572.1%	186,583 $5.51 Million
Q4 2023 Feb 12, 2024	BUY	$27.14 - $34.93 $2.36 Million - $3.03 Million	86,807 Added 87.0%	186,583 $5.51 Million
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $1.51 Million - $2.01 Million	61,311 Added 159.39%	99,776 $3.15 Million
Q2 2023 Aug 11, 2023	BUY	$23.51 - $30.09 $570,399 - $730,043	24,262 Added 170.82%	38,465 $995,000
Q1 2023 May 18, 2023	BUY	$19.19 - $24.1 $270,521 - $339,737	14,097 Added 13299.06%	14,203 $341,000
Q1 2023 May 11, 2023	SELL	$19.19 - $24.1 $1.51 Million - $1.89 Million	-78,465 Reduced 99.87%	106 $2,000
Q4 2022 Feb 13, 2023	BUY	$17.59 - $23.83 $1.13 Million - $1.53 Million	64,388 Added 453.98%	78,571 $1.53 Million
Q3 2022 Nov 14, 2022	BUY	$19.98 - $29.44 $80,879 - $119,173	4,048 Added 39.94%	14,183 $299,000
Q2 2022 Aug 11, 2022	BUY	$18.42 - $27.5 $88,710 - $132,440	4,816 Added 90.54%	10,135 $197,000
Q1 2022 May 11, 2022	SELL	$15.5 - $23.93 $267,375 - $412,792	-17,250 Reduced 76.43%	5,319 $117,000
Q4 2021 Feb 10, 2022	BUY	$13.05 - $19.35 $33,577 - $49,787	2,573 Added 12.87%	22,569 $360,000
Q3 2021 Nov 12, 2021	BUY	$13.95 - $20.18 $278,944 - $403,519	19,996 New	19,996 $399,000

Others Institutions Holding MIRM

# of Institutions

225

Shares Held

55.4M

Call Options Held

27.4K

Put Options Held

105K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.63B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Mirum Pharmaceuticals, Inc. Transaction History